Ophthalmic insights

The US Food and Drug Administration (FDA) has approved Yuvezzi (carbachol and brimonidine tartrate), a once-daily eye drop to treat...

A new study has found that spectacle lenses using Highly Aspherical Lenslet Target (HALT) technology may slow the progression of...

Researchers at Cedars-Sinai Medical Center in the US have established a link between bacterium in the retina and cognitive decline...

Belgian investment holding company Groupe Bruxelles Lambert (GBL) is investing €500 million (AU$840  million) in British ophthalmic manufacturer Rayner. An...

Two young optometrists are redefining early-career independence, launching a revitalised community practice in Perth and proving that ambition, teamwork and...

Defocus incorporated multiple segments (DIMS) spectacle lenses can slow myopia progression in children without accelerating astigmatism, according to a prospective...

Victorian fund BGH Capital has reportedly taken a nearly 50% stake in Perth-born Two Svge, a direct-to-consumer supplier of bold...

Geographic atrophy (GA) continues to present significant challenges in both diagnosis and long-term patient management, as emerging therapies and evolving...

A global surge in myopia is expected to significantly contribute to a sharp increase in open-angle glaucoma cases over the...

New research suggests there are many challenges when encouraging different age groups into contact lenses. But for those practices willing...